# Health risk analysis of micro-and nanoplastic exposure via the microbiota-gut-brain axis

**Authors:** Xuan Wang, Haoming Yu, Jihong Li, Shengyu Han, Yuhua Chi

PMC · DOI: 10.3389/fimmu.2026.1762813 · Frontiers in Immunology · 2026-02-18

## TL;DR

This paper explores how micro- and nanoplastics affect human health by disrupting the gut microbiota and its connection to the brain.

## Contribution

The paper provides a comprehensive review of the pathways and impacts of micro- and nanoplastics on the microbiota-gut-brain axis.

## Key findings

- Micro- and nanoplastics accumulate in the gastrointestinal tract and disrupt intestinal microbiota.
- These particles may affect the microbiota-gut-brain axis through neural, immune, and endocrine pathways.
- Current research highlights the potential for microplastics to induce or worsen diseases.

## Abstract

As global plastic pollution continues to intensify, micro- and nanoplastics have emerged as novel environmental pollutants threatening human health. These particles enter the human body through dietary ingestion, inhalation, and skin contact,accumulating within the gastrointestinal tract. Their disruption of the intestinal microbiota has become a recent research focus. Studies indicate that micro- and nanoplastics can interfere with the normal mechanisms of the microbiota-gut-brain axis via neural, immune, and endocrine pathways, thereby inducing or exacerbating diseases. This paper reviews the exposure pathways and intestinal accumulation characteristics of micro- and nanoplastics in humans, the composition of normal gut microbiota and their metabolic products, elucidates the functional pathways of the microbiota-gut-brain axis and the potential impacts of microplastics upon entering the human body, and summarises the current research status, limitations, and future prospects.

## Full-text entities

- **Genes:** TNF-alpha [NCBI Gene 493755], ADRA1B (adrenoceptor alpha 1B) [NCBI Gene 147] {aka ADRA1, ALPHA1BAR}, POMC (proopiomelanocortin) [NCBI Gene 5443] {aka ACTH, CLIP, LPH, MSH, NPP, OBAIRH}, ACHE (acetylcholinesterase (Yt blood group)) [NCBI Gene 43] {aka ACEE, ARACHE, N-ACHE, YT}, ARR3 (arrestin 3) [NCBI Gene 407] {aka ARRX, MYP26, cArr}, CHRNG (cholinergic receptor nicotinic gamma subunit) [NCBI Gene 1146] {aka ACHRG}, HCRTR2 (hypocretin receptor 2) [NCBI Gene 3062] {aka ORXR2, OX2R, OXR2}, SLC6A9 (solute carrier family 6 member 9) [NCBI Gene 6536] {aka GCENSG, GLYT1, IS6}, Ahr (aryl-hydrocarbon receptor) [NCBI Gene 11622] {aka Ah, Ahh, Ahre, In, bHLHe76}, mucin [NCBI Gene 100508689], GLUL (glutamate-ammonia ligase) [NCBI Gene 2752] {aka DEE116, GLNS, GS, PIG43, PIG59}, TJP1 (tight junction protein 1) [NCBI Gene 7082] {aka ZO-1}, NLRP3 [NCBI Gene 101092579], IL-1beta [NCBI Gene 768274], CHRM4 (cholinergic receptor muscarinic 4) [NCBI Gene 1132] {aka HM4, M4R}, CRH (corticotropin releasing hormone) [NCBI Gene 1392] {aka CRF, CRH1}, IL-6 [NCBI Gene 493687], MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615] {aka IMD68, MYD88D, WM1}, HTR3A (5-hydroxytryptamine receptor 3A) [NCBI Gene 3359] {aka 5-HT-3, 5-HT3A, 5-HT3R, 5HT3R, HTR3}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, FFAR2 (free fatty acid receptor 2) [NCBI Gene 2867] {aka FFA2R, GPR43}, AVP (arginine vasopressin) [NCBI Gene 551] {aka ADH, ARVP, AVP-NPII, AVRP, VP}, GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}, GCG (glucagon) [NCBI Gene 2641] {aka GLP-1, GLP1, GLP2, GRPP}, PYY (peptide YY) [NCBI Gene 5697] {aka PYY-I, PYY1}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, MUC13 (mucin 13, cell surface associated) [NCBI Gene 56667] {aka DRCC1, MUC-13}, CREB3 (cAMP responsive element binding protein 3) [NCBI Gene 10488] {aka LUMAN, LZIP, sLZIP}, UCP2 (uncoupling protein 2) [NCBI Gene 7351] {aka BMIQ4, SLC25A8, UCPH}, PLG (plasminogen) [NCBI Gene 5340] {aka HAE4}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, S1PR4 (sphingosine-1-phosphate receptor 4) [NCBI Gene 8698] {aka EDG6, LPC1, S1P4, SLP4}, AGRP (agouti related neuropeptide) [NCBI Gene 181] {aka AGRT, ART, ASIP2}
- **Diseases:** acute (MESH:D000208), intestinal barrier (MESH:D007410), ischemia (MESH:D007511), Neurological disorders (MESH:D009461), metabolic disorders (MESH:D008659), nervous system disorders (MESH:D009422), anxiety disorders (MESH:D001008), organ dysfunctions (MESH:D009102), arrhythmias (MESH:D001145), mucosal injury (MESH:D052016), obesity (MESH:D009765), depression (MESH:D003866), IBD (MESH:D015212), IBS (MESH:D043183), neuronal death (MESH:D009410), mood disorders (MESH:D019964), stroke (MESH:D020521), impair learning and memory (MESH:D007859), diabetes (MESH:D003920), gastrointestinal diseases (MESH:D005767), Dysfunction of the noradrenergic system (MESH:D007154), Dysbiosis (MESH:D064806), colitis (MESH:D003092), Alzheimer's disease (MESH:D000544), neurotoxic (MESH:D020258), cardiovascular disease (MESH:D002318), Dysfunction of the central dopaminergic system (MESH:D002493), schizophrenia (MESH:D012559), neuroinflammation (MESH:D000090862), anxiety (MESH:D001007), toxicity (MESH:D064420), epileptic (MESH:D004827), cerebral disorders (MESH:D002547), glioma (MESH:D005910), behavioural abnormalities (MESH:D000014), reperfusion injury (MESH:D015427), thrombus (MESH:D013927), neurodegeneration (MESH:D019636), injuries (MESH:D014947), chronic inflammation (MESH:D007249), Parkinson's disease (MESH:D010300), atherosclerosis (MESH:D050197), anhedonia (MESH:D059445), neurological damage (MESH:D020196)
- **Chemicals:** hydrogen (MESH:D006859), PET (MESH:D011093), Glutamate (MESH:D018698), GABA (MESH:D005680), acetate (MESH:D000085), NE (MESH:D009638), DA (MESH:D004298), SCFA (MESH:D005232), heavy metal (MESH:D019216), polycyclic aromatic hydrocarbons (MESH:D011084), MP (MESH:D000080545), ROS (MESH:D017382), 5-HT (MESH:D012701), ketone bodies (MESH:D007657), nitric oxide (MESH:D009569), cholesterol (MESH:D002784), HDPE (MESH:D020959), PS (MESH:D011137), water (MESH:D014867), propionic acid (MESH:C029658), acetylcholine (MESH:D000109), PP (MESH:D011126), LPS (MESH:D008070), MGBA (MESH:C057056), lipid (MESH:D008055), cortisol (MESH:D006854), Butyrate (MESH:D002087), carbon (MESH:D002244), PVC (MESH:D011143), polymer (MESH:D011108), propionate (MESH:D011422), bile acids (MESH:D001647), P-PS (-), superoxide (MESH:D013481), oxygen (MESH:D010100), salt (MESH:D012492)
- **Species:** Romboutsia ilealis (species) [taxon 1115758], Bacteroidia (class) [taxon 200643], Bacillota (clostridial firmicutes, phylum) [taxon 1239], Paracentrotus lividus (common sea urchin, species) [taxon 7656], Mus musculus (house mouse, species) [taxon 10090], Cyprinus carpio (carp, species) [taxon 7962], Homo sapiens (human, species) [taxon 9606], Danio rerio (leopard danio, species) [taxon 7955], Escherichia coli (E. coli, species) [taxon 562]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12957245/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12957245/full.md

## References

112 references — full list in the complete paper: https://tomesphere.com/paper/PMC12957245/full.md

---
Source: https://tomesphere.com/paper/PMC12957245